MedTrace Logo

24-Wk β-Alanine Ingestion on Muscle Taurine and Clinical Blood Parameters in Healthy Males

NCT03655041 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25

Last updated 2018-08-31

No results posted yet for this study

Summary

Although β-alanine (BA) has been shown to be an effective ergogenic aid, little information exists on the safety of chronic supplementation despite potential concerns. The aim of this study was to investigate the effects of chronic BA supplementation on muscle taurine content, blood clinical markers and sensory side-effects during 24 weeks of BA supplementation.

Conditions

  • Sports Nutritional Physiological Phenomena

Interventions

DIETARY_SUPPLEMENT

Beta-alanine

Beta-alanine in sustained-release tablets to increase muscle carnosine content

DIETARY_SUPPLEMENT

Placebo

Maltodextrin is used as a placebo as it does not lead to any increases in muscle carnosine

Sponsors & Collaborators

  • University of Sao Paulo

    lead OTHER

Principal Investigators

  • Bruno Gualano, PhD · University of Sao Paulo

Study Design

Allocation
RANDOMIZED
Purpose
OTHER
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
40 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-02-01
Primary Completion
2015-12-15
Completion
2017-12-15

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03655041 on ClinicalTrials.gov